Smart apiculture management services for developing countries-the case of SAMS project in Ethiopia and Indonesia.

The European Union funded project SAMS (Smart Apiculture Management Services) enhances international cooperation of ICT (Information and Communication Technologies) and sustainable agriculture between EU and developing countries in pursuit of the EU commitment to the UN Sustainable Development Goal "End hunger, achieve food security and improved nutrition and promote sustainable agriculture". The project consortium comprises four partners from Europe (two from Germany, Austria, and Latvia) and two partners each from Ethiopia and Indonesia. Beekeeping with small-scale operations provides suitable innovation labs for the demonstration and dissemination of cost-effective and easy-to-use open source ICT applications in developing countries.

Phase II trial of gemcitabine/irinotecan in refractory or relapsed small-cell lung cancer.

Background: Gemcitabine and irinotecan have shown a broad range of activity in solid tumors, including small-cell lung cancer (SCLC), with a synergistic effect on SCLC cell lines. The objective of this phase II trial was to evaluate the activity of gemcitabine/irinotecan in patients with relapsed SCLC.

Patients And Methods: Thirty-five patients (15 with refractory disease and 20 with sensitive disease) who had experienced treatment failure with 1 previous chemotherapy regimen were recruited.

Clinical benefit in NSCLC: advanced-stage patients require symptom-improving palliation. Experiences from the 'Iressa' expanded access program.

Background: The molecular genesis of lung cancer and its treatment remain hot spots of medical research because of the high mortality rates especially associated with non-small-cell lung cancer (NSCLC). New agents are required. The epidermal growth factor receptor (EGFR) pathway inhibitor gefitinib (Iressa) has been the first approved drug for NSCLC within this new therapeutic class.